• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Emerging Cancer Vaccine Market, The

$3,500.00 – $7,000.00

Clear
SKU: KLI923607 Category: Pharmaceuticals Market Research Pages: 226
  • Description
  • Table of Contents
  • Latest reports

Description

Immunologic approaches to cancer therapy are not only increasing in reputation and number, but the market for these products is increasingly becoming a reality. Vaccines are in the forefront of this approach to cancer, and the handful of cancer vaccine products currently on the market for bladder, colon, and skin cancer are soon to be joined by many more with indications for more wide-spread forms, including lung, breast, ovarian, prostate, leukemia, and others.

This new study from Kalorama discusses the emerging vaccine technologies and the competitive and clinical landscape in which they will emerge. Extensive interviewing of industry participants has revealed the revenues of the existing competitors that we belive have never been published, and market models based on epidemiology, likely clinical acceptance, and regulatory events and validated with this existing revenue information predicts market size, growth, and share for emerging products in the United States and the world through 2008.

Table of Contents

Chapter One: Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

Chapter Two: The Emerging Cancer Vaccine Market

  • History and Growth of the Cancer Treatment Market
  • Cancer Vaccine Technology
  • Industry Structure
  • Demographics and Statistics

Chapter Three: Current Cancer Vaccine Market

  • Overview
  • Description of Cancers with Available Vaccines
    • Bladder Cancer
    • Colorectal Cancer
    • Melanoma
  • Description of Products
    • TheraCys (ImmuCyst)
    • M-Vax
    • Melacine
    • OncoVax
    • Pacis
  • Market Size and Growth
  • Competitive Analysis

Chapter Four: Emerging Cancer Vaccine Potential

  • Overview
    • Description of Cancers with Potential Vaccines
      • Breast Cancer
      • Cervical Cancer
      • Colorectal Cancer
      • Gastrointestinal Cancer
        • Stomach
        • Liver
        • Pancreas
      • Kidney
      • Leukemia
      • Lung Cancer
      • Lymphoma
      • Melanoma
      • Multiple Myeloma
      • Neuroblastoma
      • Ovarian Cancer
      • Prostate Cancer
      • Sarcoma
  • Cancer Vaccine Pipeline
    • Phase III
    • Phase II
    • Phase I
  • Market and Product Launch Forecasts
  • Potential Competitors and Analysis, 2008

Chapter Five: Issues and Trends Affecting the Cancer Vaccine Market

  • Introduction
  • Early Detection and Screening
  • Insurance and Reimbursement Issues
  • Personalized Medicine
  • Pharmacogenomics
  • Vaccine Strategies
  • New Genetic Technique
  • New application for Tobacco Plant

Chapter Six: The Emerging Cancer Vaccine Market: Total Market Size and Forecast

  • Overview
  • Total Market Size and Forecast
  • Competitor Analysis
  • Market Analysis

Chapter Seven: Corporate Profiles

  • AVAX Technologies, Inc.
  • Aventis Pasteur, Inc.
  • Corixa Corporation
  • Intracel Holdings Corporation
  • Shire Biochem, Inc.

Chapter Eight: Emerging Vaccine Corporate Profiles

  • Advaxis, Inc.
  • Aphton Corporation
  • Antigenics, Inc.
  • AVI BioPharma, Inc.
  • Berlex, Inc.
  • Biomira, Inc.
  • Biovest International, Inc.
  • CancerVax Corporation
  • Cell Genesys, Inc.
  • CYTOGEN Corporation
  • Dendreon Corporation
  • Epimmune, Inc.
  • Favrille, Inc.
  • GeneMax Corporation
  • Genitope Corporation
  • Genzyme Molecular Oncology
  • Geron Corporation
  • GlaxoSmithKline plc
  • IDM, S.A.
  • ImClone Systems, Inc.
  • Immune Response Corporation, The
  • Large Scale Biology Corporation
  • Medarex, Inc.
  • MedImmune, Inc.
  • Merck & Company, Inc.
  • Northwest Biotherapeutics, Inc.
  • Oxford BioMedica plc
  • Progenics Pharmaceuticals, Inc.
  • Therion Biologics Corporation
  • Titan Pharmaceuticals, Inc.
  • Transgene S.A.
  • United Biomedical, Inc.
  • Vical, Inc.
  • Wyeth
  • YM BioSciences, Inc.

Appendix A: Company Names and Addresses

Appendix B: Regulatory Authorities and Organizations

List of Exhibits

Chapter One: Executive Summary

  • Table 1-1: Current and Emerging Market – Cancer Vaccines, 2001-2008
  • Figure 1-1: Current and Emerging Market – Cancer Vaccines, 2001-2008

Chapter Two: The Emerging Cancer Vaccine Market

  • Table 2-1: Estimated and Projected World Cancer Incidence by Common Type of Cancer, 2003 and 2020
  • Figure 2-1: Estimated and Projected World Cancer Incidence by Common Type of Cancer, 2003 and 2020
  • Table 2-2: Estimated and Projected World Cancer Mortality by Common Type of Cancer, 2003 and 2020
  • Figure 2-2: Estimated and Projected World Cancer Mortality by Common Type of Cancer, 2003 and 2020
  • Table 2-3: World Population by Selected Geographical Region, 2003-2050
  • Figure 2-3: World Population by Selected Geographical Region, 2003-2050
  • Table 2-4: Estimated World Population by Age and Geographical Region, 2003
  • Figure 2-4: Estimated World Population by Age and Geographical Region, 2003
  • Table 2-5: Life Expectancy at Birth by Selected Countries, 2000
  • Table 2-6: United States Life Expectancy at Birth, 1990-2000, and Projections, 2005-2010
  • Figure 2-5: United States Average Years of Life Lost Per Person Dying of Cancer, All Races, Both Sexes, 2000
  • Figure 2-6: United States Estimated Person-Years of Life Lost Due to Cancer, All Races, Both Sexes, 2000

Chapter Three: Current Cancer Vaccine Market

  • Table 3-1: Malignant Conditions Of The Skin
  • Table 3-2: Cancer Vaccines: Estimated World Incidence and Mortality of Cancers with Potential Vaccines
  • Figure 3-1: Cancer Vaccines: Estimated World Incidence and Mortality of Cancers with Potential Vaccines
  • Table 3-3: Current Cancer Vaccines Market, 2001-2008
  • Figure 3-2: Current Cancer Vaccines Market, 2001-2008
  • Table 3-4: Leading Suppliers Shares by Market Revenues, Estimated 2003
  • Figure 3-3: Leading Suppliers Market Share, Estimated 2003

Chapter Four: Emerging Cancer Vaccine Potential

  • Table 4-1: Types of Leukemia
  • Table 4-2: Types of Primary Lung Cancer
  • Table 4-3: Classification of Non-Hodgkin’s Lymphomas
  • Table 4-4: Malignant Conditions of The Skin
  • Table 4-5: Cancer Vaccines: Estimated World Incidence and Mortality of Cancers with Potential Vaccines
  • Figure 4-1: Cancer Vaccines: Estimated World Incidence and Mortality of Cancers with Potential Vaccines
  • Table 4-6: Cancer Vaccines in the Pipeline
  • Table 4-7: Cancer Vaccines: Emerging Cancer Vaccines Market, 2004-2008
  • Figure 4-2 Cancer Vaccines: Emerging Cancer Vaccines Market, 2004-2008
  • Table 4-8: Cancer Vaccines: Emerging Cancer Vaccines Market by Type, 2004-2008
  • Table 4-9: Cancer Vaccines: Emerging Cancer Vaccines Market by Type – Revenues and Percent Distribution, 2004-2008
  • Figure 4-3: Cancer Vaccines: Emerging Cancer Vaccines Market by Type – Revenues and Percent Distribution, 2004-2008
  • Figure 4-4: Cancer Vaccines: Emerging Cancer Vaccines Market by Percent Distribution, 2004-2008
  • Figure 4-5: Cancer Vaccines: Emerging Cancer Vaccines Market by Percent andProduct Type, 2008
  • Table 4-10: Leading Suppliers Shares by Market Revenues, Based on Emerging Vaccines – Projected 2008
  • Figure 4-6: Leading Suppliers Shares by Market Revenues, Based on Emerging Vaccines – Projected 2008
  • Table 4-11: Competitors by Cancer Vaccine Type, Based on Emerging Vaccines – Projected 2008
  • Figure 4-7: Competitors by Cancer Vaccine Type, Based on Emerging Vaccines – Projected 2008

Chapter Five: Issues and Trends Affecting the Cancer Vaccine Market

  • Table 5-1: Cancer Detection Tests

Chapter Six: The Emerging Cancer Vaccine Market: Total Market Size and Forecast

  • Table 6-1: Cancer Vaccines, 2001-2008
  • Figure 6-1: Cancer Vaccines, 2001-2008
  • Table 6-2: Cancer Vaccines by Current and Emerging Markets, 2001-2008
  • Table 6-3: Cancer Vaccines by Current and Emerging Market Revenues and Percent Distribution, 2001-2008
  • Figure 6-2: Cancer Vaccines by Current and Emerging Market Revenues and Percent Distribution, 2001-2008
  • Figure 6-3: Cancer Vaccines Current and Emerging Markets by Percent Distribution, 2001-2008
  • Figure 6-4: Current and Emerging Cancer Vaccines Market by Percent, 2008
  • Table 6-4: Cancer Vaccines: Current and Emerging Suppliers and Developers of Cancer Vaccines by Cancer Type
  • Figure 6-5: Cancer Vaccines: Competitors by Cancer Vaccine Type and Number of Products Available or in Development
  • Figure 6-6: Cancer Vaccines: Cancer Vaccines Available or in Development by Cancer Type, 2003
  • Figure 6-7:Cancer Vaccines: Competitors by Cancer Vaccine Availability and/or Number of Vaccines in Development
  • Figure 6-8: Cancer Vaccines: Competitors by Cancer Vaccine Availability and/or Number of Vaccines in Development

 

    Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals
    May 22, 2023
    Precision Cancer Therapeutics Market, 2022
    October 25, 2022
    The World Market for Vaccines, 2022-2027
    September 23, 2022
    Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
    August 2, 2022

Related products

  • Placeholder image

    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    $2,812.00 – $5,625.00
  • Placeholder image

    Emerging Cancer Vaccine Market, The

    $3,500.00 – $7,000.00
  • Placeholder image

    Worldwide Market for Prescription Dermatological Drugs – 4th Edition, The

    $3,500.00 – $7,000.00
  • Placeholder image

    Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices

    $2,995.00 – $5,990.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023
  • IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East September 15, 2023
  • Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market September 6, 2023
  • The Wide-Reaching Potential of Artificial Intelligence in Healthcare August 28, 2023
  • IVD for Pets: A $2.7 Billion Global Market July 24, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Outsourcing in Drug Development – The Contract Research Market from Preclinical...Worldwide Market for Prescription Dermatological Drugs – 4th Edition,...
Scroll to top